Drug intelligence / Profile preview

MEMOPTIC

Development stage
Unknown
Lead developer
Densmore
Modality
Small Molecules
Administration
Oral
01

Overview

MEMOPTIC is an oral combination product formulated as a tablet containing citicoline, magnesium, and *Ginkgo biloba* extract. It is primarily utilized as a neuroprotective agent in the field of ophthalmology, specifically as an adjunctive therapy for patients with chronic open-angle glaucoma. The formulation aims to preserve visual function and protect the optic nerve from degeneration, complementing conventional intraocular pressure-lowering treatments. Citicoline (cytidine 5'-diphosphocholine) serves as a precursor for the synthesis of phosphatidylcholine, a major component of neuronal membranes, and has demonstrated potential in treating glaucoma, amblyopia, and ischemic optic neuropathies. *Ginkgo biloba* extract provides antioxidant properties and enhances microcirculation, while magnesium acts as a natural antagonist of NMDA receptors to mitigate glutamate-induced excitotoxicity. MEMOPTIC is typically marketed as a dietary supplement or nutraceutical.

Brand names
MEMOPTIC
02

Targets

NMDAR (Glutamate receptor ionotropic, NMDA)PTAFR (Platelet-activating factor receptor)

Beyond the preview

Go deeper on MEMOPTIC.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MEMOPTIC.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call